Cardiovascular Disease Risk Factors Predict the Development of Type 2 Diabetes
The Insulin Resistance Atherosclerosis Study
- Ralph B. D’Agostino, Jr, PHD1,
- Richard F. Hamman, MD, DRPH2,
- Andrew J. Karter, PHD3,
- Leena Mykkanen, MD4,
- Lynne E. Wagenknecht, DRPH1,
- Steven M. Haffner, MD, MPH5 and
- for the Insulin Resistance Atherosclerosis Study Investigators
- 1Department of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina
- 2Department of Preventive Medicine and Biometrics, University of Colorado, Health Science Center, Denver, Colorado
- 3Division of Research, Kaiser Permanente, Oakland, California
- 4Department of Medicine, University of Kuopio, Kuopio, Finland
- 5Department of Medicine, University of Texas Health Sciences Center at San Antonio, San Antonio, Texas
- Address correspondence and reprint requests to Ralph D’Agostino, Jr., PhD, Department of Public Health Science, Biostatistics Section, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157. E-mail: rdagosti{at}wfubmc.edu
Abstract
OBJECTIVE—In a few previous studies, cardiovascular disease (CVD) risk factors (RFs) have been shown to predict diabetes. Our objective was to determine whether the presence of CVD RFs predict the eventual development of diabetes after controlling for known RFs, such as directly measured insulin resistance and obesity.
RESEARCH DESIGN AND METHODS—We studied 872 participants with normal or impaired glucose tolerance (IGT) who were enrolled at baseline in the Insulin Resistance Atherosclerosis Study (IRAS). Of these, 143 (16%) developed type 2 diabetes in 5 years. Using these participants, a series of logistic regression models were fit to address the question.
RESULTS—Significant RFs for developing type 2 diabetes included high plasminogen activator inhibitor-1, hypertension, high triglycerides, low levels of HDL cholesterol, and IGT. The 5-year cumulative incidence of type 2 diabetes by the number of RFs (0–5) was as follows: no RFs, 11 of 230 = 5%; one RF, 31 of 278 = 11%; two RFs, 36 of 202 = 18%; three RFs, 41 of 110 = 37%; four RFs, 19 of 42 = 45%; and five RFs, 5 of 10 = 50% (P < 0.001). The odds ratio (OR) for conversion to type 2 diabetes for each additional RF was 2.1 (95% CI 1.78–2.46) after adjusting for age, sex, ethnicity, and center. After further adjustment for insulin resistance, determined by the frequently sampled intravenous glucose tolerance test and waist circumference, each additional CVD RF increased the risk of type 2 diabetes significantly (OR 1.81, 95% CI 1.49–2.20).
CONCLUSIONS—Individuals with multiple CVD RFs are at increased risk of type 2 diabetes, which is only partially mediated by insulin resistance or central adiposity. This information should be useful for identifying high-risk patients for developing diabetes through RF assessments.
- ATP-III, National Cholesterol Evaluation Program Adult Treatment Panel III
- CVD, cardiovascular disease
- IGT, impaired glucose tolerance
- IRAS, Insulin Resistance Atherosclerosis Study
- NGT, normal glucose tolerance
- OGTT, oral glucose tolerance test
- PAI, plasminogen activator inhibitor
- RF, risk factor
- TG, triglyceride
- WST, waist circumference
Footnotes
-
A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.
-
- Accepted June 16, 2004.
- Received October 29, 2003.
- DIABETES CARE














